Mark J. Cooper
Impact in
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- Retinal Development and Disorders
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
- Ophthalmology top 2%
- Retinal Diseases and Treatments
Papers in
-
- RNA Interference and Gene Delivery 32
- Advanced biosensing and bioanalysis techniques 25
- Retinal Development and Disorders 15
- CRISPR and Genetic Engineering 4
- Genetics 15
- Virus-based gene therapy research 10
- Co-authors
- Muna I. Naash (17 shared papers)Shannon M. Conley (9 shared papers)Rasha Makkia (9 shared papers)Tomasz Kowalczyk (9 shared papers)Pamela B. Davis (4 shared papers)Zongchao Han (6 shared papers)Susannah L. Hyatt (7 shared papers)Linas Padegimas (13 shared papers)
- Journals
- Molecular Therapy (7 papers)Journal of Controlled Release (5 papers)Investigative Ophthalmology & Visual Science (4 papers)PLoS ONE (4 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Mark J. Cooper
55 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 2.2k
- Ophthalmology 268
- Pharmaceutical Science 163
- Genetics 672
- Cellular and Molecular Neuroscience 381
Countries citing papers authored by Mark J. Cooper
This map shows the geographic impact of Mark J. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Cooper more than expected).
Fields of papers citing papers by Mark J. Cooper
This network shows the impact of papers produced by Mark J. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Cooper. The network helps show where Mark J. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 218 | |
| 2 | 2006 | 169 | |
| 3 | 2003 | 155 | |
| 4 | 1988 | 140 | |
| 5 | 2003 | 137 | |
| 6 | 2012 | 123 | |
| 7 | 2001 | 121 | |
| 8 | 2006 | 118 | |
| 9 | 2007 | 111 | |
| 10 | 2009 | 100 | |
| 11 | 2009 | 90 | |
| 12 | 2003 | 78 | |
| 13 | 2011 | 76 | |
| 14 | 2012 | 74 | |
| 15 | 2011 | 73 | |
| 16 | 1995 | 72 | |
| 17 | 2003 | 70 | |
| 18 | 2009 | 65 | |
| 19 | 2013 | 65 | |
| 20 | 2009 | 56 |
About Mark J. Cooper
Mark J. Cooper is a scholar working on Molecular Biology, Genetics, Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Developmental Neuroscience, having authored 55 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (32 papers), Advanced biosensing and bioanalysis techniques (25 papers), Retinal Development and Disorders (15 papers), Virus-based gene therapy research (10 papers), Nerve injury and regeneration (6 papers), Cystic Fibrosis Research Advances (4 papers), CRISPR and Genetic Engineering (4 papers) and Neonatal Respiratory Health Research (4 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Ophthalmology (268 citations), Pharmaceutical Science (163 citations), Genetics (672 citations) and Cellular and Molecular Neuroscience (381 citations). Mark J. Cooper has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Muna I. Naash, Shannon M. Conley, Rasha Makkia, Tomasz Kowalczyk, Pamela B. Davis, Zongchao Han, Susannah L. Hyatt, Linas Padegimas, Murali K. Pasumarthy and Robert C. Moen. Their work appears in journals such as Molecular Therapy, Journal of Controlled Release, Investigative Ophthalmology & Visual Science, PLoS ONE and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.